Re-defining Parkinson's disease.

Area of Science:

• Neurology
• Neuroscience
• Pathology

Background:

• Non-motor symptoms are increasingly recognized as crucial in Parkinson's disease (PD) progression.
• Existing definitions of PD may not fully encompass the diverse clinical presentations and underlying pathology.
• Understanding the anatomical and neurobiological basis of these symptoms is essential for a comprehensive disorder definition.

Purpose of the Study:

• To critically re-define and update the classification of Parkinson's disease.
• To propose a novel definition of PD based on integrated clinical, neuroanatomical, and neurobiological findings.
• To identify a core anatomical definition applicable to most PD subtypes.

Main Methods:

• Review and synthesis of epidemiological and clinical studies on PD patients.
• Inclusion of experimental findings related to PD pathology.
• Analysis of anatomical alterations and their clustering into distinct disease phenotypes.

Main Results:

• Parkinson's disease presents with diverse phenotypes, differing in onset, progression, severity, and non-motor symptom clusters.
• Specific anatomical alterations underlie the varied symptoms observed in PD patients.
• A core anatomical definition, involving brainstem monoamine nuclei, is identified across most PD subgroups, excluding specific autosomal recessive disorders.

Conclusions:

• A novel definition of Parkinson's disease is proposed, integrating clinical, neuroanatomical, and neurobiological data.
• The diverse pathologies of PD can be collectively defined as a monoamine brainstem disorder (MBD).
• This re-definition facilitates a more accurate understanding and classification of Parkinson's disease.